Boston Scientific signs deal with BG Medicine to use heart diagnostic test

03/31/2011 | MassDevice.com (Boston)

BG Medicine has entered an agreement with Boston Scientific allowing the latter to use its galectin-3 test for heart failure to pinpoint patients who might be candidates for a cardiac resynchronization treatment. The deal will allow Boston Scientific to use BG's biomarker discovery technologies to identify other biomarkers that could help predict patients' responses to the therapy.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA